Ledger.Open graph →

SEC Form D · filed December 3, 2015

Predictive Therapeutics Ltd

Offering

—

Sold

$2.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

REHOVOT, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Robert Harow · Rehovot, L3Exec · Director Asher Nathan · Rehovot, L3Exec Mariano Delle Donne · Greenwood Village, COExec Doug Wilwerding · Greenwood Village, COExec · Director Robert M. W. Baird & Co. Incorporated · Boulder, COExec · Director Brian M. Beitner · Boulder, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗